Picture of Catalyst Pharmaceuticals logo

CPRX — Catalyst Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapSuper Stock

Brief: Catalyst Pharmaceuticals Q1 Revenue USD 149.4 Million Vs. IBES Estimate USD 148.2 Million

May 11 (Reuters) - Catalyst Pharmaceuticals Q1 operating income USD 73.2 million.

Q1 net income USD 63.7 million

Recent news on Catalyst Pharmaceuticals

See all news